Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients
吸烟特征在预测肺癌患者新辅助免疫治疗的病理反应方面优于程序性死亡配体1表达。
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-21-734
Yang, Haitang; Ma, Wenyan; Sun, Beibei; Fan, Liwen; Xu, Ke; Hall, Sean R R; Al-Hurani, Mohammad Faisal; Schmid, Ralph A; Peng, Ren-Wang; Hida, Toyoaki; Wang, Zhexin; Yao, Feng